References
J. R. Koup, D. J. Greenblatt, W. J. Jusko, T. W. Smith, and J. W. Koch-Weser. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.J. Pharmacokin. Biopharm. 3:181–192 (1975).
T. W. Smith and E. Haber. Digoxin intoxication: The relationship of clinical presentation to serum digoxin concentration.J. Clin. Invest. 49:2377–2386 (1970).
T. W. Smith, V. P. Butler, Jr., and E. Haber. Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.Biochemistry 9:331–337 (1970).
T. W. Smith and E. Haber. Clinical value of the radioimmunoassay of the digitalis glyoosides.Pharmacol. Rev. 25:219–228 (1973).
T. W. Smith and E. Kaplan. Radioimmunoassay of cardiac glycosides. In H. W. Strauss, B. Pitt, and A. E. James (eds.),Cardiovascular Nuclear Medicine, Mosby, St. Louis, 1974, pp. 348–365.
T. W. Smith. Measurement of cardiac glycoside concentrations in serum or plasma: Technical problems and clinical implications. In M. N. Croll, L. W. Brady, T. Honda, and R. J. Wallner (eds.),Techniques in Tumor Localization and Radioimmunoassay, Wiley, New York, 1974, pp. 25–37.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, T.W. Digoxin radioimmunoassay: Capabilities and limitations. Journal of Pharmacokinetics and Biopharmaceutics 4, 197–198 (1976). https://doi.org/10.1007/BF01086154
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01086154